Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immatics NV
(NQ:
IMTX
)
11.81
+0.08 (+0.68%)
Streaming Delayed Price
Updated: 9:52 AM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immatics NV
< Previous
1
2
3
Next >
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
September 16, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 06, 2024
From
https://immatics.com/
Via
GlobeNewswire
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Immatics Shares Are Rising Today
July 24, 2023
Immatics N.V. (NASDAQ: IMTX) shares are trading higher after the company announced
Via
Benzinga
Recap: Immatics Q1 Earnings
May 16, 2023
Via
Benzinga
Why Immatics Stock Is Soaring Today
May 02, 2023
Investors liked what they heard in Immatics' interim results for experimental immunotherapy IMA203.
Via
The Motley Fool
Immatics Announces Second Quarter 2024 Financial Results and Business Update
August 13, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Appoints Alise Reicin to Board of Directors
July 31, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
July 18, 2024
From
https://immatics.com/
Via
GlobeNewswire
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
May 24, 2024
Via
Benzinga
Immatics Announces First Quarter 2024 Financial Results and Business Update
May 14, 2024
From
https://immatics.com/
Via
GlobeNewswire
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Immatics Announces Full Year 2023 Financial Results and Corporate Update
March 21, 2024
From
https://immatics.com/
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Immatics Announces Pricing of $175 Million Public Offering
January 17, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Proposed Public Offering
January 17, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Third Quarter 2023 Financial Results and Business Update
November 14, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
November 08, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
October 24, 2023
From
https://immatics.com/
Via
GlobeNewswire
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
Via
ACCESSWIRE
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Second Quarter 2023 Financial Results and Business Update
August 17, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid Tumors
August 10, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb
July 24, 2023
From
https://immatics.com/
Via
GlobeNewswire
Top 5 Health Care Stocks That May Crash This Month
June 22, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Immatics Announces First Quarter 2023 Financial Results and Business Update
May 16, 2023
From
https://immatics.com/
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 02, 2023
Via
Benzinga
What's Going On With Immatics Shares Today
May 02, 2023
Immatics N.V. (NASDAQ: IMTX) shares are shooting higher today after it revealed an interim clinical data update for 11 patients with recurrent and/or refractory solid cancers treated with ACTengine...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.